The expression levels of NEK2, DLGAP5 and ECT2 were similar to those in our training cohort, with significant differences in expression between tumor and normal (Fig. 3A,C,E), suggesting that the differential expression statuses of these three genes is a common feature of lung cancer. The gene discussed is ECT2; the disease is neoplasm.